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Background
Four dimensional flow MRI is a new methodology for
evaluating the morphology of the heart using phase con-
trast cardiac magnetic resonance imaging not only in the
usual three dimensions (x, y and z), but also across time.
The full breadth of this new form of imaging has yet to be
fully established. In order to evaluate this modality and its
accuracy, we decided to use 4D flow MRI to quantify dia-
stolic flow volumes across a bioprosthetic valve (BPV) in a
controlled and reproducible in vitro system.
Methods
Three different sizes of BMV’s (27, 29, and 31 mm)
were consecutively mounted in an MRI compatible flow
loop where the flow conditions could be controlled
using software that programmed a pump to generate
pulsatile, physiologic ventricular ejection and filling
simulations. The generated pulses were generated using
each valve and mimicked diastolic flow volumes of
about 70, 90 and 110 ml/beat at a rate of 70 bpm. An
in-series ultrasonic flow transducer (UFT) was used to
measure flow (L/min) by which diastolic flow volumes
were determined. The acquisition of 3D cine (4D flow)
phase contrast velocity data was acquired in a 1.5 Tesla
MRI scanner (Avanto, Siemens Medical Solutions, Inc.,
Erlangen, Germany). The typical imaging parameters
were: repetition time 45-48 ms, echo time 2.75 ms, flip
angle 15°, slice thickness 1.5 mm, field of view 350 ×
260 mm2, voxel size 1.5 × 1 × 1.25 mm3. The flow
measurements were determined at 3 locations within
the valve in post-imaging examination including at the
valve base, leaflet tips, and midway between the base
and the tips.
Results
When 4D flow volume measurements were compared to
UFT diastolic flow volumes, the average difference was
-0.2 ± 3.0 ml/beat. For all flow condition tested (n = 8),
the 4D flow measurements were strongly correlated to the
reference standard flow meter, regardless of measurement
location within the bioprosthesis (Pearson correlation, r =
0.98, 0.99, and 0.99 for the base, mid, and tips location,
respectively. p < 0.001).
Conclusions
4D flow MRI can be used as a considerably accurate tool
for assessing bioprosthetic mitral valve diastolic inflow
volume when compared to the reference standard measure.
The imaging plane chosen for trans-valvular flow analysis
did not affect the accuracy of the 4D flow measurements.
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